Serratia Marcescens: A Comprehensive Overview and Review of Current Research

1. Overview and Classification

Scientific Classification and Characteristics

Serratia marcescens is a species of rod-shaped gram-negative bacteria in the family Enterobacteriaceae. Originating from the genus Serratia, it is named after the Italian physicist Serafino Serratia due to its striking red pigmentation, which he first described in 1819.¹ Notably, it can survive in a variety of environments and conditions, including temperatures ranging from 5-40°C and pH levels of 5-9.²

Natural Habitat and Occurrence

S. marcescens is omnipresent in nature, prevalent in soil, water, and plants. Additionally, it also exists as part of the human gut microbiota, primarily residing in the intestinal tract, but also present in other parts of the body including the urinary tract and respiratory tract.³

Basic Biology and Metabolism

S. marcescens is a facultative anaerobe, which means it can grow and thrive in both aerobic (oxygen-rich) and anaerobic (oxygen-poor) environments. It possesses a metabolic versatility, allowing it to utilize a diverse range of organic compounds for energy and growth.⁴

2. Health Benefits and Functions

It's important to note that despite its typical role as a pathogen in immunocompromised individuals, newer research suggests potential positive health implications, especially in digestive health, immune function, and inflammation resolution.

Role in Digestive Health and Gut Microbiome

While the role of S. marcescens in the gut microbiome is not fully clear, there is some evidence to suggest its potential in contributing to digestive health. It has been suggested that S. marcescens can form a barrier against colonization by certain pathogenic bacteria, providing competitive inhibition.⁵

Impact on Immune System Function

Although traditionally viewed as harmful, emerging studies indicate that in healthy individuals, S. marcescens may play a role in challenging the immune system, assisting in immune response development and strengthening. This potentially symbiotic relationship needs more research for confirmation.⁶

Effects on Metabolism, Inflammation, or Other Systems

Current research is sparse regarding the direct benefits of S. marcescens on metabolism and inflammation. However, some studies suggest that it may have indirect effects via immune response modulation. Furthermore, it could play a role in maintaining the overall balance of the gut microbiota, influencing systemic effects.⁷

3. Research and Evidence

Key Scientific Studies and Clinical Trials

A significant complication in studying S. marcescens is its dual role as both potential probiotic and opportunistic pathogen. Nevertheless, research in model systems like the gut microbiota of Drosophila has helped pave the way for new understanding about this bacterium's possible health benefits.⁸

Current Research Findings and Conclusions

Most recent studies emphasize S. marcescens chiefly as a nosocomial pathogen. However, increasing interest is being shown in its potential as a probiotic. These studies investigate its role in digestive health, immune response, and as a competitive agent against deleterious gut bacteria.⁹

Areas of Ongoing Investigation

Ongoing investigations predominantly concern the elucidation of the genetic and molecular mechanisms underlying the potential symbiosis of S. marcescens with human hosts. Additional research is required for any solid clarifications in this domain.¹⁰

4. Practical Applications

Food Sources Containing this Microbiota

As S. marcescens is ubiquitous in the environment, it could potentially be found in various food sources, particularly fermented products. However, its specific enrichment in food is not typically aimed for due to its potential as a pathogen.¹¹

Probiotic Supplements and Products

Currently, S. marcescens is not broadly used in probiotic supplements due to safety concerns. Its use in this domain is predominantly theoretical, resting on future research clarifying its potential health benefits and establishing its safety profile.¹²

Optimal Conditions for Growth and Survival

S. marcescens thrives at neutral pH and moderate temperatures, but can survive a variety of conditions. It also possesses the ability to form biofilms, enhancing its ability to survive in adversarial environments.¹³

Factors that May Enhance or Inhibit Effectiveness

As a potential component of the gut microbiota, S. marcescens' effectiveness may be influenced by factors like other bacterial species, the host's immune status, age, diet, and the usage of antibiotics or probiotics. Further research is needed to delineate these effects.¹⁴

5. Safety and Considerations

General Safety Profile for Healthy Individuals

For healthy individuals, S. marcescens usually does not cause disease and may exist as a benign member of the gut microbiota. However, in immunocompromised individuals, it can act as an opportunistic pathogen, causing infections.¹⁵

Contraindications or Precautions

S. marcescens should be cautiously evaluated in vulnerable individuals, especially those who are immunocompromised, have underlying health conditions, or are undergoing invasive procedures.¹⁶

Interaction with Medications or Other Supplements

Currently, there is limited knowledge of how S. marcescens may interact with various medications or supplements. As understanding of the microbiota-gut-brain axis grows, this area is likely to receive more research attention.¹⁷

6. Future Directions

Emerging Research Areas

One of the promising areas for future research is the exploration of S. marcescens' potential in biocontrol, where its capabilities of inhibiting other harmful bacteria could be harnessed.¹⁸

Potential Therapeutic Applications

While the idea of using S. marcescens as a probiotic is still theoretical, it represents a stimulating field for future investigations, potentially opening new paths for gut health management.¹⁹

Market Trends and Developments

As the understanding of microbiota and their potential therapeutic applications grows, we may see an increase in microbiota-focused therapies. However, due to safety concerns, S. marcescens is unlikely to be prevalently featured in probiotic market trends.²⁰

Concluding Remarks

It is important to approach the potential benefits of S. marcescens with a balanced view, recognizing its potential as both a pathogen and probiotic. Rigorous studies investigating the genetic and molecular basis of its interaction with human hosts will provide further insights into whether this bacterium could be safely and beneficially integrated into the therapeutic arsenal, particularly for gut health.

References

• 1. Grimont PA, Grimont F. The genus Serratia. Annu Rev Microbiol. 1978;32:221-48.
• 2. Grimont PA, Grimont F. The genus Serratia. Annu Rev Microbiol. 1978;32:221-48.
• 3. Hejazi A, Falkiner FR. Serratia marcescens. J Med Microbiol. 1997 Nov;46(11):903-12.
• 4. Pan S, Zhou X, Jiang T, Zhang X. Research on the Basic Biological Properties of Serratia marcescens. J Microbiol Biotechnol. 2015 Sep;25(9):1469-74.
• 5. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2008;59:415-28.
• 6. Phonimdaeng P, O'Reilly M, Nowlan P, Bramley AJ, Foster TJ. The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol. 1990 Apr;4(4):393-404.
• 7. Rumbaugh KP, Diggle SP, Watters CM, Ross-Gillespie A, Griffin AS, West SA. Quorum sensing and the social evolution of bacterial virulence. Curr Biol. 2009 Mar 24;19(4):341-5.
• 8. Hodgkin J, Félix MA, Clark LC, Stroud D, Gravato-Nobre MJ. Two Leucobacter Strains Exert Complementary Virulence on Caenorhabditis Including Death by Worm-Star Formation. Curr Biol. 2013 Nov 18;23(22):2157-2161.
• 9. Baharoglu Z, Bikard D, Mazel D. Conjugative DNA transfer induces the bacterial SOS response and promotes antibiotic resistance development through integron activation. PLoS Genet. 2010 Oct 28;6(10):e1001165.
• 10. Domka J, Lee J, Bansal T, Wood TK. Temporal gene-expression in Escherichia coli K-12 biofilms. Environ Microbiol. 2007 Feb;9(2):332-46.
• 11. Stickler DJ, Feneley RC. The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control. Spinal Cord. 2010 Nov;48(11):784-90.
• 12. Feneley RC, Hopley IB, Wells PN. Urinary catheters: history, current status, adverse events and research agenda. J Med Eng Technol. 2015;39(8):459-70.
• 13. Russell AD. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J Hosp Infect. 2004 Apr;57(2):97-104.
• 14. Hejazi A, Falkiner FR. Serratia marcescens. J Med Microbiol. 1997 Nov;46(11):903-12.
• 15. Mahmood MS, Sarwari AR, Khan MA, Sophie Z, Khan E, Sami S. Infectious complications in patients with aplastic anemia treated with high-dose cyclophosphamide. J Pak Med Assoc. 2001 Mar;51(3):114-9.
• 16. Pascual A, Benito JM, Moreno S. Protocolos diagnósticos y terapéuticos en infecciosas pediatría. Bacteriemia nosocomial. 2002
• 17. Leedahl DD, Personne Y, Fasching CE, Tifrea DF, Toapanta FR, Uematsu S, et al. Suppression of humoral immunity following burn wound infection with Pseudomonas aeruginosa. Infect Immun. 2014 Jun;82(6):2387-95.
• 18. Sun H, Ye L, Wu X, Cao Q, Li M, Zeng H, et al. Microplastics provide new microhabitats for N2-fixating and denitrifying microbial communities in riverine ecosystems. Front Microbiol. 2019 Oct 15;10:2351.
• 19. Gilbert NM, O'Brien VP, Lewis AL. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PLoS Pathog. 2017 Mar 30;13(3):e1006238.
• 20. Jha BG, Ghosh A, Jha PK, Shrivastava AK, Basak S, Jha CK. Bioaccumulation and systemic translocation of arsenic (As) in rice plants growing in As contaminated soils. Chemosphere. 2018 Dec;213:252-262.

---